Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (25626)	9/22/1998 9:38:00 AM
From: Wallace Rivers	Read Replies (1) \| Respond to of 32384

*OT*My area of expertise is none of your business. So far this year, your calls for LGND to trade in high double digits or above, would indicate where your area of expertise is not, even discounting a poor overall market, and biotech market. Believe it or not, I do appreciate your highlights of BARS or H&Q updates. I merely think that focus on trading minutiae is of extremely limited use, at best. And, it is apparent to me, at least, that you focus in on this minutiae almost exclusively when it is on the + ticks. If it is a function of the "naysayers" to point out that there are investment risks in what is a most speculative stock with negative earnings, I'm happy to be included in that group. That said, I am positive long term on the prospects for LGND.